Home Search
immunotherapy - search results
If you're not happy with the results, please do another search
Biocept, UCSD Med Center Partner on Clinical Validation Study for PD-L1 Assay in NSCLC
Biocept and University of California San Diego (UCSD) Medical Center will assess the company’s Target Selector assay in NSCLC patients
CRISPR/Cas9 Can Create Killer T Cells Highly Sensitive to Cancer Cell Antigens
The engineered killer T cells are 1,000 times more sensitive to cancer cell antigens to allow much better targeting to cancer cell lines
Leukemia & Lymphoma Society Awards $46M in Research Grants
The new funding increases to 254 the number of active LLS grants and features 23 in precision medicine and 17 in immunotherapy projects
March of the Microbes
Researchers are harnessing the power of the human microbiome to improve health and target disease
MSK’s Approved NGS-Based Tumor Panel Leads to FDA Assay Review Pathway
Memorial Sloan Kettering Cancer Center wins FDA authorization for MSK-IMPACT assay, the first tumor-profiling LDT to win agency approval
Illumina’s Flatley Describes the “Shock and Awe” of Personalized Medicine at PMC
Flatley receives Personalized Medicine Coalition's Lifetime Achievement Award and uses occasion to detail his views on personalized medicine
Epic Sciences Adds Analyses to Enhance Patient Selection for Cancer Immunotherapies
Epic Sciences adds simultaneous microsatellite instability and chromosomal instability analyses to its cancer immunotherapy NGS workflow
Gut Microbiome Makeup Instrumental in Response to Anti-PD-1 Therapy for Melanoma
A probiotic regimen to alter the gut microbiome could be beneficial for patients receiving anti-PD-1 immunotherapy for melanoma
IsoPlexis Wins $1.8M NCI SBIR Grant toward Platform to Assess CAR-T Therapies
IsoPlexis has won a $1.8 million NCI SBIR grant to develop a platform designed to help predict patient response to CAR-T cell therapies
![MedGenome has raised $30M in Series C financing toward advancing biomarker discovery programs and its OncoPept™ cancer immunotherapy biomarker solutions. [Source: 3desc/Fotolia]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1224-150x150.jpeg "MedGenome Completes $30M Series C Financing")
MedGenome Completes $30M Series C Financing
MedGenome has raised $30M in Series C financing toward biomarker discovery programs and OncoPept cancer immunotherapy biomarker solutions
